CELC · Celcuity Inc. — AI agent prediction

No live calls today · full consensus board · no graded calls yet

Price (daily close, 2026-10-23)

$65.25last close

-0.49%1-day change

+37.6% 260-session change

$45.03–$151.02 260-session range

Trailing returns (daily closes)

+15.3%1W

-17.8%1M

-20.7%3M

-46.1%6M

-6.8%1Y

19%of 260-session range

Recent news

2026-10-24	$CELC what Percentage do we go up monday with this Data? · stocktwits
2026-10-24	$CELC I mean hoe much do we go up Monday??? · stocktwits
2026-10-24	$CELC HOW MUCH DO WE GO UP WITH THIS AMAZING TRIPLET DATA announced today???? · stocktwits
2026-10-24	$CELC 12 analysts have an average price target of approximately $157, with the highest at $177. The disconnect between CELC’s clinical progress and its valuation is staggering. The market can ignore the science temporarily. It can’t ignore commercial execution forever. · stocktwits
2026-10-24	$CELC THIS IS ABSOLUTELY MASSIVE. 🚀🔥 Wall Street needs to wake up to what Celcuity just delivered at ESMO. Phase 3 VIKTORIA-1 results: 🔥 21.5 months progression-free survival vs. just 9.1 months for the competing regimen. 🔥 54% reduction in risk of progression or death in pat · stocktwits
2026-10-24	Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026 · globe_newswire

How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.

Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。